How to Get Vanflyta (Quizartinib) Covered by Aetna CVS Health in California: Complete Appeal Guide with Forms and Timelines
Answer Box: Getting Vanflyta Covered by Aetna CVS Health in California
Vanflyta (quizartinib) requires prior authorization from Aetna CVS Health for FLT3-ITD positive AML. Key requirements: confirmed FLT3-ITD mutation via FDA-approved test, baseline EKG with QTc ≤450ms, and oncologist prescription. If denied, California residents can appeal internally within 180 days,